Annual Report on Medical Professionalism
The project explores alternative pathways for the discovery, development and distribution of new drug products. It is funded jointly with the
Open Society Institute.
Together with
Community Catalyst IMAP recently launched the
The Prescription Project, a national campaign to promote evidence based decision making and stricter control of conflicts of interest in physician-pharmaceutical industry relationships.
In collaboration with the
ABIM Foundation, IMAP has developed
recommendations for managing conflicts of interest between physicians and pharmaceutical companies.
Over the past year, the New York City Department of Health has launched programs targeting both diabetes and HIV/AIDS for more systematic and expanded reporting, surveillance, and direct intervention in the doctor-patient relationship. These two proposals may well be a harbinger of a national trend to broaden the powers of the public health system. The recent CDC recommendations on HIV/AIDS, as well as efforts to significantly revise the HIV-testing procedure in other cities such as San Francisco, serve as further indication of a shift towards a heightened authority of public health officials to monitor and intervene directly in the doctor-patient relationship, and the reporting and management of disease. This project aims to analyze both initiatives in diabetes and HIV/AIDS, with an awareness to ensure that both measures are justified and effective and do not have a negative impact on access to care.
The fellowship seeks to make advocacy a core professional value for physicians. It supports the development and enhancement of advocacy skills by partnering physicians with advocacy organizations.
The project will be investigating the attitudes of physicians towards patient privacy in light of competing demands. It will document and analyze physician behaviors aimed at protecting patient privacy.
IMAP is now exploring how medical professionalism can become relevant to healthcare in other countries.
In collaboration with Community Catalyst, IMAP will be analyzing the influence of pharmaceutical industry funding on the policies and practices of professional medical societies and consumer healthcare organizations.
The project focuses on the dynamics of the relationship (past and present) between the tobacco industry and the medical profession. It is funded jointly with the American Legacy Foundation.
A fundamental shift has occurred in what Americans define as their social obligations; once considered to be part of a collective responsibility,obligations are now being abandoned, even repudiated. Well aware that a deep commitment to individuals and their rights does not deflect us from a basic commitment to collective responsibilities, presenters will explore the question of what the community owes the individual.
